Nasdaq:US$18.51 (-0.40) | HKEX:HK$30.25 (-0.75) | AIM:£3.00 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations | 12 Oct 2023

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor